Global Nuclear Medicine/Radiopharmaceuticals Market - Market Size, Share & Industry Trends, Growth Analysis Report By Type, By Application, By Procedural Volume Assessment and Forecast 2019 - 2025


DescriptionTable of ContentList of TablesList of Figures
Introduction
Nuclear Medicine/Radiopharmaceuticals Market was valued at USD XX Billion in 2019 and is projected to reach USD XX billion by 2025, at a CAGR of XX% from 2020-2025. The high growth of nuclear medicines across the globe is the major driver for the increase in the Nuclear Medicine/Radiopharmaceuticals Market. Factors such as increasing cancer, cardiac ailments and various related diseases are also heavily contributing to the growth of this market. Increasing awareness among people and various government initiates and facilities to provide prevalent patients with adequate diagnosis and care are also improving the conditions of the market in various continents. Easy availability and the initiatives taken by various organizations to lessen the demand-supply gap of Mo-99 and other related radioactive elements used to is also forecasted to significantly increase the Nuclear Medicine/Radiopharmaceuticals Market.
On the other hand, factors like short life of radioactive pharmaceuticals, the storage, and transport and logistics difficulties of these elements and also the high cost hinders the growth of the market in various regions.
Geographical Overview
At global level, North America region holds the highest market share in 2019 due to the advanced facilities and infrastructure available. Whereas, Asia Pacific region is considered the fastest-growing region with key players adopting expansion strategy in this region to gain maximum market share in the coming years. China and India are offering ample opportunities for the growth of Nuclear Medicine/Radiopharmaceuticals Market with its high population base. Key factors such as government initiatives and changing infrastructures of the regions are also driving Nuclear Medicine/Radiopharmaceuticals Market in the Asia Pacific region.
?
Segmental Overview
Nuclear Medicine/Radiopharmaceuticals Market is segmented as per below specifications -  
By Type:
•	Diagnostic Nuclear Medicine
o	SPECT Radiopharmaceuticals
?	Technetium-99m
?	Thallium-201
?	Gallium-67
?	Iodine-123
?	Other SPECT Isotopes
o	PET Radiopharmaceuticals
?	F-18
?	Ru-82
?	Other PET Isotopes
•	Therapeutic Nuclear Medicine
o	Alpha Emitters
?	Ra-223
o	Beta Emitters
?	Iodine-131
?	Yttrium-90
?	Samarium-153
?	Lutetium-177
?	Rhenium-186
?	Other Beta Emitters
•	Brachytherapy Isotopes
o	Iodine-125
o	Palladium-103
o	Cesium-131
o	Iridium-192
o	Other Brachytherapy Isotopes
By Application:
•	Diagnostic Applications
o	SPECT Applications
o	Cardiology
?	Bone Scans
?	Thyroid Applications
?	Pulmonary Scans
?	Other SPECT Applications
o	PET Applications
?	Oncology
?	Cardiology
?	Neurology
?	Other PET Applications
o	Therapeutic Applications
?	Thyroid Indications
?	Bone Metastasis
?	Lymphoma
?	Endocrine Tumors
?	Other Indications
By Procedural Volume Assessment:
•	Diagnostic Procedures
o	SPECT Procedures
o	PET Procedures
•	Therapeutic Procedures
o	Beta Emitter Procedures
o	Alpha Emitter Procedures
o	Brachytherapy Procedures

Competitor Analysis
Nuclear Medicine/Radiopharmaceuticals Market has presence of some of the key major players across globe which includes
•	Advanced Accelerator Applications S.A.
•	Iba Molecular
•	Nordion, Inc. 
•	Eczacibasi-Monrol Nuclear Products
•	Siemens Healthcare
•	Sigma Aldrich Corporation
•	Bracco Imaging S.P.A
•	Bayer AG
•	Jubilant Pharma
•	Nordien, Inc.
•	Lantheus Medical Imaging, Inc.
•	GE Healthcare 
•	Mallinckrodt PLC
•	Cardinal Health, Inc.
•	Medtronic Plc.
These key players are concentrating its efforts on the continuous product improvement with innovative initiatives to have an edge over other competitors. Further, to garner maximum market share, companies are adopting merger/ acquisition/ partnership and maintaining strong distribution networks strategies.  
By Geographical Locations: 
•	North America
o	U.S.
o	Canada
•	Europe
o	U.K.
o	France
o	Italy
o	Germany
o	Spain
o	Russia & CIS
o	Rest of Europe
•	Asia-Pacific
o	China 
o	India
o	Japan
o	South Korea
o	ASEAN
o	Rest of Asia Pacific 
•	Latin America
o	Brazil
o	Argentina
o	Rest of LATAM
•	Middle East & Africa
o	UAE
o	South Africa
o	Rest of MEA
?
Highlights of the report
What is Nuclear Medicine/Radiopharmaceuticals Market?
Who all are key market players in the industry?
How the Parent Industry is growing?
Where are the key opportunities for new market entrant?
A comprehensive analysis, which covers key growth factors across the value chain
Recent developments in market
Granular Market Segmentation 
Market size projection based on Historical & current market trends 
Market share analysis and key strategies adopted by Leading Players
Production Cost & Sensitivity Analysis
Country Level Market Analysis of Top 16 countries
Data Driven Decision Recommendations